We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
PURITAN MEDICAL

Download Mobile App




Stryker Signs Agreement to Buy Sage Products

By HospiMedica International staff writers
Posted on 16 Feb 2016
Stryker Corporation (Kalamazoo, MI, USA) has announced a definitive agreement to acquire Sage Products (Cary, IL, USA) from Madison Dearborn Partners (Chicago, IL, USA), in an all cash transaction.

Sage develops, manufactures and distributes disposable products targeted at reducing never events, primarily in the intensive care unit (ICU) and medical/surgical hospital unit setting. More...
Examples include decontaminants to ward off infections, cloths to clean incontinent patients, specialized hospital furniture, and tools to reduce the risk of caretaker injury. Other products include solutions for oral care, skin preparation and protection, patient cleaning and hygiene, turning and positioning devices, and heel care boots.

The acquisition, valued at of USD 2.775 billion, will also provide a consistent disposable revenue stream that will complement Stryker capital equipment offerings, and demonstrates that reducing hospital-acquired infections has become a top priority for med tech players, mainly due to US federal government incentives. For example, Sage's patient turning and repositioning system, designed to prevent sacral pressure ulcers, will be complementary to Stryker's hospital bed business.

“This acquisition aligns with Stryker's focus on offering products and services that support a mindset of prevention, specifically in the area of “never events” such as hospital acquired infections,” said Kevin A. Lobo, Chairman and CEO of Stryker. “Sage has a 45-year history of focus on patients and caregivers that is evident in their culture and fits well with our Medical division. This business will also provide a consistent disposable revenue stream that will complement our capital equipment offerings.”

"Over our 45 years, we have achieved incredible growth through our focus on innovation, our Sage culture, and our deep commitment to our community,” said Scott Brown, President and CEO of Sage Products. “We are grateful for Madison Dearborn's partnership over the past few years and believe that Sage is well-positioned for continued achievement and long-term success with Stryker, a company that understands our business, supports our goals and embraces our values.”

Stryker has been following an acquisition-driven strategy to boost growth over the last three years, resulting in a total of eleven targeted deals that have greatly expanded its product portfolio, with most of the acquisitions provided product lines that are complementary to Stryker’s existing product line. The company recently stated that mergers and acquisitions are its top priority.

Related Links:

Stryker Corporation
Sage Products
Madison Dearborn Partners 



Gold Member
SARS‑CoV‑2/Flu A/Flu B/RSV Sample-To-Answer Test
SARS‑CoV‑2/Flu A/Flu B/RSV Cartridge (CE-IVD)
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Radiation Safety Barrier
RayShield Intensi-Barrier
Digital Color Doppler Ultrasound System
MS22Plus
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.